|\ |\ |\ |\ |\ |\
answers
Which of the following was NOT a requirement of the original
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
Food Drug and Cosmetic Act of 1938? a) Proof of efficacy b) Proof
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
of safety c) Authorized standards of identify d) Safe tolerances
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
for unavoidable poisonous substances(1:1) - CORRECT ANSWERS
|\ |\ |\ |\ |\ |\ |\
✔✔A: Proof of efficacy|\ |\ |\
Which amendments to the FD&C Act resulted from the
|\ |\ |\ |\ |\ |\ |\ |\ |\
thalidomide tragedy? a) Durham-Humphrey Amendments b) |\ |\ |\ |\ |\ |\
Hatch-Waxman Act c) Controlled Substances Act d) Kefauver- |\ |\ |\ |\ |\ |\ |\
Harris Amendments (1:2) - CORRECT ANSWERS ✔✔D: Kefauver-
|\ |\ |\ |\ |\ |\ |\
Harris Amendments |\
The Color Additive Amendment of 1960 required FDA to prove
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
that a color additive was unsafe before removing it from the
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
market. a) True b) False(1:3) - CORRECT ANSWERS ✔✔B: False
|\ |\ |\ |\ |\ |\ |\ |\ |\
What has been described as "the most extensive change to the
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
agency's practices since 1938?" a) Prescription Drug User Fee Act
|\ |\ |\ |\ |\ |\ |\ |\ |\
of 1922b) GMPs for the 21st Century initiative c) Food and Drug
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
Administration Modernization Act d) Food and Drug |\ |\ |\ |\ |\ |\ |\
Administration Amendments Act(1:4) - CORRECT ANSWERS ✔✔C: |\ |\ |\ |\ |\ |\ |\
Food and Drug Administration Modernization Act
|\ |\ |\ |\ |\
,Both regulations and guidance documents have the force of law.
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
True or False?(2:1) - CORRECT ANSWERS ✔✔False. Only
|\ |\ |\ |\ |\ |\ |\ |\
regulations have the force of law. |\ |\ |\ |\ |\
Although FDA's statutory authority does not extend to the
|\ |\ |\ |\ |\ |\ |\ |\ |\
occupational safety and health responsibilities of OSHA the |\ |\ |\ |\ |\ |\ |\ |\
agencies coordinate their efforts in matters of related
|\ |\ |\ |\ |\ |\ |\ |\
responsibility such as unshielded syringes and natural rubber |\ |\ |\ |\ |\ |\ |\ |\
latex. True or False?(2:2) - CORRECT ANSWERS ✔✔True
|\ |\ |\ |\ |\ |\ |\
An FDA petition much contain which of the following? a) Action
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
requested b) Statement of grounds c) Environmental impact d)
|\ |\ |\ |\ |\ |\ |\ |\ |\
All of the above(2:3) - CORRECT ANSWERS ✔✔D: All of the above
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
Drugs may be eligible for over-the-counter status when: a) They
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
have been marketed to a material extent b) They have been
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
marketed for a material time c) Are generally recognized as safe
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
d) All of the above(2:4) - CORRECT ANSWERS ✔✔D: All of the
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
above
Biologics are cleared for marketing through which process ?a)
|\ |\ |\ |\ |\ |\ |\ |\ |\
Establishment License Application (ELA)b) Product License |\ |\ |\ |\ |\ |\
Application (PLA)c) Biologics License Application (BLA)d) All of the
|\ |\ |\ |\ |\ |\ |\ |\
above(2:5) - CORRECT ANSWERS ✔✔C: Biologics License
|\ |\ |\ |\ |\ |\ |\ |\
Application (BLA) |\
A Special 510(k) relies on the following information: a) Design
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
control documentation b) Guidance documents c) Consensus
|\ |\ |\ |\ |\ |\ |\
standards d) All of the above(2:6) - CORRECT ANSWERS ✔✔A:
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
Design control documentation |\ |\
, Which act required rulemaking meetings to be open to the
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
public? a) Moonshine Act b) Government in the Sunshine Act c)
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
Food Drug and Cosmetics Act d) Administrative Amendments
|\ |\ |\ |\ |\ |\ |\ |\
Act(2:7) - CORRECT ANSWERS ✔✔B: Government in the Sunshine
|\ |\ |\ |\ |\ |\ |\ |\
Act
|\
Which of the following does not distinguish the development of
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
drugs for animal use from those for human use: a) The ability to
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
use known data from the development of a drug for use in
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
humans or other animal species as applicable. b) Generally
|\ |\ |\ |\ |\ |\ |\ |\ |\
safety and efficacy studies require only 10s of animals per group
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
compared to the 100s of patients per group required for human |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
drugs. c) Does not have user fees for NADAs. d) Species class
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
and breed of animals as well as geographical differences are
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
more relevant.(3:1) - CORRECT ANSWERS ✔✔C: Does not have
|\ |\ |\ |\ |\ |\ |\ |\ |\
user fees for NADAs.|\ |\ |\
A generic drug is deemed bioequivalent to the RLD if in clinical
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
bioequivalence studies the 90% confidence intervals for the ratio |\ |\ |\ |\ |\ |\ |\ |\ |\
of population geometric means between the two treatments
|\ |\ |\ |\ |\ |\ |\ |\
based on log-transformed data is contained within the
|\ |\ |\ |\ |\ |\ |\ |\
equivalence limits of ____% - ____% for AUC and Cmax. a) 80 120 |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
b) 75 125 c) 90 110 d) 80 125(3:2) - CORRECT ANSWERS ✔✔D:
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
80% and 125% |\ |\
What is the definition of a biologic?(3:3) - CORRECT ANSWERS
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\
✔✔A substance derived from or made with the aid of living
|\ |\ |\ |\ |\ |\ |\ |\ |\ |\ |\
organisms.